Investor Relations

Virax Biolabs is an innovative Biotechnology company focused on the prevention, detection and diagnosis of viral diseases. The company is a revenue generating group operating since 2013 whose primary business is the proprietary development and global distribution of in vitro diagnostic (IVD) test kits.

Virax Immune is our flagship product focused on the global provision of T-Cell tests, which accurately and effectively predict an individual's immune response to significant viral threats. This life impacting product offering is scheduled to be available for distribution Q3 2022. Virax also offers a range of In Vitro Diagnostic devices, AI sanitizers and other innovative technologies through its’ ViraxClear and ViraxCare platforms.

For more information sign up for our newsletter.
register here


  • Benzinga Interview with Chief Executive, James Foster

    4 August 2022
    Benzinga, Benzinga Content Studio

    read article

  • Virax Biolabs Introduces Monkeypox and Varicella-Zoster Viruses Real-Time PCR Detection Kit

    26 July 2022
    Virax Biolabs, Press Releases

    read article

  • Virax Biolabs Group Limited Completes Initial Public Offering; Shares Begin Trading Today on NASDAQ Capital Market as VRAX

    21 July 2022
    Virax Biolabs, Press Releases

    read article

view all articles


  • May 2022
  • 17–20, Virtual Issuer Direct Spring Into Action Best Ideas Conference
  • 16-19, Ascot, England Biotech CEO Summit Europe
  • 23-25, Virtual/Miami H.C. Wainwright & Co. Global Life Sciences Conference
  • 26-27, New York, NY Credit Suisse 5th Healthcare Disruptive Technologies & Innovations Conference
  • June 2022
  • 1, TBD Craig-Hallum 19th Annual Institutional Investor Conference
  • 6-9, Virtual William Blair Growth Stock Conference 2022
  • 7-9, Los Angeles LD Micro Invitational XII
  • 8-10, New York, NY Jefferies Healthcare Conference
  • 13-18, San Diego, CA BIO Biotechnology International Convention
  • 14-16, Rancho Palos Verdes, CA Goldman Sachs Global Healthcare Conference
  • 16, OTC Markets International Investor Conference
  • 16, Virtual GCFF Conference 2021 – Healthcare Investment Conference
  • 21–23, Beverly Hills Gravitas Securities LA Summit
  • 22-24 New York, NY Credit Suisse Montauk Biotech Conference
  • 23 OTC Markets Life Sciences Investor Forum
  • 23, Virtual Diamond Equity Research Summer Virtual Conference
view all events